Rhenman & Partners Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,000
| Closed | -$2.82M | – | 90 |
|
|
2021
Q4 | $2.82M | Hold |
8,000
| – | – | 0.19% | 85 |
|
|
2021
Q3 | $2.04M | Hold |
8,000
| – | – | 0.14% | 86 |
|
|
2021
Q2 | $5.33M | Hold |
8,000
| – | – | 0.36% | 80 |
|
|
2021
Q1 | $6.94M | Buy |
8,000
+2,200
| +38% | +$1.91M | 0.48% | 60 |
|
|
2020
Q4 | $5.38M | Hold |
5,800
| – | – | 0.44% | 66 |
|
|
2020
Q3 | $5.96M | Hold |
5,800
| – | – | 0.53% | 58 |
|
|
2020
Q2 | $5.88M | Sell |
5,800
-4,200
| -42% | -$4.26M | 0.63% | 56 |
|
|
2020
Q1 | $8.69M | Sell |
10,000
-1,000
| -9% | -$869K | 1.22% | 36 |
|
|
2019
Q4 | $11.8M | Sell |
11,000
-800
| -7% | -$858K | 1.29% | 33 |
|
|
2019
Q3 | $10.9M | Sell |
11,800
-2,098
| -15% | -$1.94M | 1.37% | 30 |
|
|
2019
Q2 | $15.7M | Buy |
13,898
+6,318
| +83% | +$7.14M | 1.73% | 23 |
|
|
2019
Q1 | $10.3M | Sell |
7,580
-4,489
| -37% | -$6.1M | 1.2% | 34 |
|
|
2018
Q4 | $14M | Buy |
12,069
+2,021
| +20% | +$2.34M | 1.6% | 27 |
|
|
2018
Q3 | $15.3M | Buy |
10,048
+466
| +5% | +$708K | 1.53% | 29 |
|
|
2018
Q2 | $15M | Buy |
9,582
+2,800
| +41% | +$4.38M | 1.53% | 28 |
|
|
2018
Q1 | $7.83M | Hold |
6,782
| – | – | 0.97% | 44 |
|
|
2017
Q4 | $8.04M | Buy |
6,782
+962
| +17% | +$1.14M | 1.09% | 34 |
|
|
2017
Q3 | $7.83M | Sell |
5,820
-354
| -6% | -$476K | 1% | 39 |
|
|
2017
Q2 | $4.99M | Hold |
6,174
| – | – | 0.72% | 53 |
|
|
2017
Q1 | $3.81M | Buy |
6,174
+2,014
| +48% | +$1.24M | 0.6% | 60 |
|
|
2016
Q4 | $2.23M | Hold |
4,160
| – | – | 0.43% | 68 |
|
|
2016
Q3 | $2.15M | Sell |
4,160
-400
| -9% | -$207K | 0.34% | 77 |
|
|
2016
Q2 | $1.87M | Hold |
4,560
| – | – | 0.33% | 78 |
|
|
2016
Q1 | $2.43M | Buy |
4,560
+2,560
| +128% | +$1.36M | 0.48% | 70 |
|
|
2015
Q4 | $1.52M | Buy |
+2,000
| New | +$1.52M | 0.23% | 90 |
|